{"filing":{"accession_number":"0001104659-26-101531","cik":"0001069899","ticker":"PAHC","company_name":"PHIBRO ANIMAL HEALTH CORP","form":"8-K","filing_date":"2026-08-26","report_date":"2026-08-26","primary_document":"pahc-20260826x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926101531/pahc-20260826x8k.htm"},"events":[{"id":29784,"run_id":27282,"accession_number":"0001104659-26-101531","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Phibro Animal Health Corporation issued a press release on August 26, 2026 announcing operating results for the fourth quarter and fiscal year ended June 30, 2026, along with financial guidance for fiscal year 2027. The disclosure includes detailed financial metrics (net sales of $1,518.1 million for FY2026, net income of $99.7 million, diluted EPS of $2.43) and forward-looking guidance ($1.55–$1.60 billion in net sales for FY2027), which is the hallmark of an earnings release under Item 2.02.","company_name":"PHIBRO ANIMAL HEALTH CORP","ticker":"PAHC","filing_date":"2026-08-26","form":"8-K","submitted_at":null,"items":[{"id":32168,"accession_number":"0001104659-26-101531","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Phibro Animal Health Corporation issued a press release on August 26, 2026 announcing operating results for the fourth quarter and fiscal year ended June 30, 2026, along with financial guidance for fiscal year 2027. The disclosure includes detailed financial metrics (net sales of $1,518.1 million for FY2026, net income of $99.7 million, diluted EPS of $2.43) and forward-looking guidance ($1.55–$1.60 billion in net sales for FY2027), which is the hallmark of an earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T20:32:03.372248+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32168,"accession_number":"0001104659-26-101531","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Phibro Animal Health Corporation issued a press release on August 26, 2026 announcing operating results for the fourth quarter and fiscal year ended June 30, 2026, along with financial guidance for fiscal year 2027. The disclosure includes detailed financial metrics (net sales of $1,518.1 million for FY2026, net income of $99.7 million, diluted EPS of $2.43) and forward-looking guidance ($1.55–$1.60 billion in net sales for FY2027), which is the hallmark of an earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T20:32:03.372248+00:00","company_name":"PHIBRO ANIMAL HEALTH CORP","ticker":"PAHC","filing_date":"2026-08-26"}]}